246 related articles for article (PubMed ID: 17168396)
21. Community-acquired bacterial respiratory tract infections.
Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
[No Abstract] [Full Text] [Related]
22. Repositioning or Redirection of Antidepressant Drugs in the Treatment of Bacterial and Fungal Infections.
da Rosa TF; Machado CS; Serafin MB; Bottega A; Foletto VS; Coelho SS; Hörner R
Am J Ther; 2020; 27(5):e528-e532. PubMed ID: 31082830
[No Abstract] [Full Text] [Related]
23. Preface.
Enne VI; Johnson AP; Perry JD
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i1. PubMed ID: 27048577
[No Abstract] [Full Text] [Related]
24. Antibiotic susceptibility of bacterial isolates from 502 dogs with respiratory signs.
Rheinwald M; Hartmann K; Hähner M; Wolf G; Straubinger RK; Schulz B
Vet Rec; 2015 Apr; 176(14):357. PubMed ID: 25467146
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of PK/PD parameters of antimicrobials in the treatment of complex and extremely-resistant infections].
Horcajada JP
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():16-8. PubMed ID: 26365728
[TBL] [Abstract][Full Text] [Related]
26. [Antibiotic resistance in respiratory tract infections: what can we do?].
Flückiger U
Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
[TBL] [Abstract][Full Text] [Related]
27. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
Hiddemann W; Maschmeyer G; Runde V; Einsele H
Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
[No Abstract] [Full Text] [Related]
28. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic sensitivity of bacteria isolated in 1998 and 1999 from patients with infections of upper airways residing in Western Pomerania.
Giedrys-Kalemba S; Kaczmarek A; Bilska I; Jezierska J; Lisowska B; Michałek-Aniko D; Ruszel B; Stelmaska-Dworak E; Jursa J
Otolaryngol Pol; 2001; 55(3):299-302. PubMed ID: 11765446
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance in respiratory tract pathogens: clinical and therapeutic consequences. Proceedings of a symposium. Stockholm, Sweden, October 31-November 1, 1994.
Microb Drug Resist; 1995; 1(2):101-167. PubMed ID: 9190294
[No Abstract] [Full Text] [Related]
31. [Antibacterial preparations against nonsporulating anaerobic bacteria].
Oleĭnik II; Bychenko BD; Robustova TG; Zhdanov LP
Antibiotiki; 1984 Aug; 29(8):619-28. PubMed ID: 6385833
[No Abstract] [Full Text] [Related]
32. [The tissue effect of an antibiotic is decisive. Respiratory tract infections--intracellular pathogens].
Gabler-Sandberger E
Fortschr Med; 1992 Oct; 110(29):32-3. PubMed ID: 1427547
[No Abstract] [Full Text] [Related]
33. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
[No Abstract] [Full Text] [Related]
34. Antibacterial and antifungal drug discovery.
Persidis A
Nat Biotechnol; 1999 Nov; 17(11):1141-2. PubMed ID: 10545930
[No Abstract] [Full Text] [Related]
35. [Role of anaerobic bacteria in community-acquired respiratory pathology].
Dubreuil L
Presse Med; 1998 Sep; 27 Suppl 4():10-1. PubMed ID: 9798476
[No Abstract] [Full Text] [Related]
36. Therapeutic strategies involving antimicrobial treatment of the upper respiratory tract in small animals.
Harvey CE
J Am Vet Med Assoc; 1984 Nov; 185(10):1159-61. PubMed ID: 6392246
[No Abstract] [Full Text] [Related]
37. [Dynamic study of antibiotic resistance of bacterial environment of the ENT department].
Pal'chun VT; Kafarskaia LI; Poliakova TS; Gurov AV
Vestn Otorinolaringol; 2004; (1):53-6. PubMed ID: 15029126
[TBL] [Abstract][Full Text] [Related]
38. Treatment of respiratory infections with fosfomycin.
Menéndez A; Tutor A; Sousa AS
Chemotherapy; 1977; 23 Suppl 1():348-57. PubMed ID: 832536
[TBL] [Abstract][Full Text] [Related]
39. Trials and tribulations of antibiotic development.
Lancet Infect Dis; 2008 Apr; 8(4):209. PubMed ID: 18353256
[No Abstract] [Full Text] [Related]
40. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.
Righi E
World J Gastroenterol; 2018 Oct; 24(38):4311-4329. PubMed ID: 30344417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
